Forecasted · Cooperative Agreement
HIV/AIDS Clinical Trials Network Clinical Trials Units
National Institutes of Health, Department of Health and Human Services
Key facts
Copied from the official Grants.gov record. Last verified October 29, 2026.
- Program name
- HIV/AIDS Clinical Trials Network Clinical Trials Units
- Issuing agency
- National Institutes of Health (Department of Health and Human Services)
- Opportunity number
- RFA-AI-28-004
- Funding type
- Cooperative Agreement
- Funding purpose
- Health
- Status
- Forecasted
- Application deadline
- Forecasted · estimated close January 22, 2027 (agency estimate)
- Agency estimates
- Estimated posting: August 25, 2026. Estimated award date: December 1, 2027. Estimates can change.
- Published award range
- Not published by the agency
- Cost sharing or match required
- No
- Eligible applicants (official categories)
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see Additional Information on Eligibility)
- Relevant to
- Businesses and NonprofitsHow we determined this: Grants.gov eligibility includes small businesses or for-profit organizations. Grants.gov eligibility includes nonprofit organizations.
- Geographic restrictions
- None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.
- Assistance Listing (CFDA)
- 93.310, 93.855
- Official source
- View on Grants.gov ↗
- Application URL
- www.grants.gov/search-results-detail/361821 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.
- Source identifier
- Grants.gov opportunity ID 361821 · Funding opportunity number RFA-AI-28-004
- Posted
- April 8, 2026 · Source last updated April 8, 2026
- Last verified
- October 29, 2026 (against Grants.gov)
- Data completeness
- 92% of key fields published by the sourceNot published: published funding range.
- Record confidence
- mediumforecast — dates and amounts are agency estimates.
Eligibility details (from the agency)
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Description (from the official listing)
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance the National Institutes of Health (NIH) mission by supporting four Clinical Trials Networks (CTNs) each comprised of a Leadership and Operations Center, Statistical and Data Management Center, and Laboratory Center working with Clinical Trials Units (CTUs), to advance prevention and treatment research on HIV and HIV-associated diseases. CTNs will conduct randomized controlled clinical studies at CTUs testing innovative strategies and conduct implementation research targeted to end the HIV epidemic. This NOFO will solicit applications for CTUs providing scientific expertise to conduct these clinical trials and implementation research studies. Each CTU will include an administrative hub and domestic and/or international Clinical Research Sites to promote efficient utilization of resources and infrastructure. CTUs conduct multiple clinical studies, from more than one CTN, and can access, recruit, and retain relevant study participants. International studies produce crucial findings significantly benefiting Americans with or at-risk of HIV or HIV-related diseases.Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Agency contact
Division of AIDS
sciops@niaid.nih.gov